Product Information
Name:IACS-13909
Brand:Biosynth
Description:IACS-13909 is a drug that binds to EGFR and inhibits the kinase activity of EGFR. It is being developed as an anti-cancer drug for the treatment of cancer, with a particular focus on cancers that are resistant to ibrutinib. IACS-13909 has shown potent anticancer activity in preclinical studies, with no adverse effects on healthy cells. IACS-13909 has been used in clinical trials for the treatment of cancer, with promising results.
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:377.3 g/mol
Formula:C17H18Cl2N6
Purity:Min. 95%
Technical inquiry about: IACS-13909
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please add the desired products to your cart and manage the request from there. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.